T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 | +$4.06B | |
| 2 | +$2.93B | |
| 3 | +$2.35B | |
| 4 |
Apple
AAPL
|
+$2.27B |
| 5 |
Caterpillar
CAT
|
+$2.12B |
Top Sells
| 1 | +$3.44B | |
| 2 | +$2.51B | |
| 3 | +$2.39B | |
| 4 |
FISV
Fiserv Inc
FISV
|
+$2.2B |
| 5 |
Norfolk Southern
NSC
|
+$1.97B |
Sector Composition
| 1 | Technology | 36.31% |
| 2 | Financials | 11.66% |
| 3 | Consumer Discretionary | 10.88% |
| 4 | Communication Services | 10.76% |
| 5 | Healthcare | 9.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
926
NovaGold Resources
NG
$5.12B
| $31.8M | ﹤0.01% |
3,618,865
+3,494,533
|
|
||
|
OKLO
927
Oklo
OKLO
$9.81B
| $31.8M | ﹤0.01% |
285,280
+209,020
|
|
||
928
Corcept Therapeutics
CORT
$3.59B
| $31.8M | ﹤0.01% |
383,060
+235,968
|
|
||
929
GXO Logistics
GXO
$6.26B
| $31.8M | ﹤0.01% |
601,189
-301,368
|
|
||
|
K
930
DELISTED
Kellanova
K
| $31.6M | ﹤0.01% |
385,687
+2,987
|
|
||
931
ADMA Biologics
ADMA
$3.73B
| $31.6M | ﹤0.01% |
2,155,662
+16,422
|
|
||
932
Universal Technical Institute
UTI
$1.89B
| $31.5M | ﹤0.01% |
968,464
+931,489
|
|
||
933
Travel + Leisure Co
TNL
$4.46B
| $31.3M | ﹤0.01% |
525,919
+34,016
|
|
||
934
Box
BOX
$3.53B
| $31.3M | ﹤0.01% |
968,863
-77,203
|
|
||
935
Procept Biorobotics
PRCT
$1.57B
| $31.2M | ﹤0.01% |
875,181
-447,258
|
|
||
936
Church & Dwight Co
CHD
$23.6B
| $31M | ﹤0.01% |
354,147
-2,096
|
|
||
937
Hecla Mining
HL
$14.2B
| $31M | ﹤0.01% |
2,559,470
+1,977,735
|
|
||
938
Janux Therapeutics
JANX
$857M
| $30.9M | ﹤0.01% |
1,265,556
-527,871
|
|
||
|
GTM
939
ZoomInfo Technologies
GTM
$1.92B
| $30.9M | ﹤0.01% |
2,833,222
+2,614,810
|
|
||
940
Edison International
EIX
$27.5B
| $30.8M | ﹤0.01% |
557,470
+238
|
|
||
941
Griffon
GFF
$3.45B
| $30.7M | ﹤0.01% |
403,018
+1,486
|
|
||
942
Unity
U
$8.68B
| $30.6M | ﹤0.01% |
764,188
+528,285
|
|
||
943
Joby Aviation
JOBY
$10B
| $30.2M | ﹤0.01% |
1,872,086
+899,713
|
|
||
944
IDEAYA Biosciences
IDYA
$2.99B
| $30.2M | ﹤0.01% |
1,109,740
-795,176
|
|
||
945
Biohaven
BHVN
$1.57B
| $30.2M | ﹤0.01% |
2,009,611
-1,161,624
|
|
||
946
West Pharmaceutical
WST
$17.2B
| $30.1M | ﹤0.01% |
114,545
-3,084
|
|
||
947
Halliburton
HAL
$30.1B
| $30M | ﹤0.01% |
1,220,336
-21,059
|
|
||
948
Allison Transmission
ALSN
$9.37B
| $29.9M | ﹤0.01% |
352,580
+35,100
|
|
||
949
Apogee Therapeutics
APGE
$5.14B
| $29.8M | ﹤0.01% |
750,529
-10,315
|
|
||
950
Wave Life Sciences
WVE
$2.65B
| $29.6M | ﹤0.01% |
4,044,492
-1,145,911
|
|